Background
==========

Eukaryotic rRNAs contain a large number of nucleotide modifications including 2\'-O-methylation and pseudouridylation which are directed by box C/D snoRNAs and box H/ACA snoRNAs, respectively \[[@B1],[@B2]\]. These modifications are usually found in the conserved core regions of rRNAs, and they play important roles in ribosome function \[[@B3]\]. SnoRNAs are among the most numerous and functionally diverse non-coding RNAs currently known \[[@B4],[@B5]\], existing widely in eukaryotes including human \[[@B6]-[@B8]\], plants \[[@B9]-[@B11]\], yeasts \[[@B12]-[@B15]\] and protists \[[@B16]-[@B19]\], as well as in Archaea \[[@B20]\]. This indicates that they are ancient molecules that arose over 2-3 billion years ago \[[@B21]\]. In addition to guiding the posttranscriptional modifications of rRNAs in eukaryotes and Archaea, snoRNAs also interact with spliceosomal RNAs \[[@B22]\], tRNAs \[[@B23],[@B24]\], SL RNAs in trypanosomes \[[@B25]\], and at least one brain-specific mRNA in mammals \[[@B26]\]. Recently, snoRNA U50 was found to be a candidate tumor suppressor gene in prostate cancer \[[@B27]\]. The existence of substantial numbers of orphan snoRNAs indicates that snoRNAs also participate in diverse biological processes that remain to be identified \[[@B4]\].

SnoRNAs exhibit canonical sequence motifs and structural features. Box C/D snoRNAs carry the conserved box C (RUGAUGA, where R can be any purine) and D (CUGA) motifs near their 5\' and 3\' termini, respectively. Additionally, the variants of the C and D boxes, designated C\' and D\' box, are usually present internally \[[@B28]\]. Box H/ACA snoRNAs possess a hairpin-hinge-hairpin-tail secondary structure and two conserved sequence motifs, box H and box ACA. The hinge region contains the H box (ANANNA) and the tail consists of the ACA box located 3 nt before the 3\' end \[[@B29],[@B30]\]. The snoRNAs exert their functions by base-pairing with their targets and recruit related proteins to the sites of modification \[[@B31]\]. Box C/D snoRNAs can form 10-21 basepairs (bp) with multiple cellular RNAs. The methylated nucleotide in the target RNA is usually positioned 5 nt upstream of the D or D\' box of the snoRNAs, the so called \"D/D\'+5\" rule \[[@B6]\]. In box H/ACA snoRNAs, two short antisense sequences in one or both of the two hairpin domains form 9-13 basepairs with rRNA sequences that flank the target uridine to be converted to pseudouridine. The pseudouridine is always located 14 to 16 nt upstream from the H box or the ACA box of the snoRNA \[[@B29],[@B30]\]. These structural and functional features of box C/D and H/ACA snoRNAs provide the parameters for identifying snoRNAs and their function.

The genomic organization of snoRNA genes displays great diversity in different organisms. In vertebrates, almost all snoRNA genes are located in the introns of host genes, with a few exceptions, such as U3 which are independently transcribed \[[@B4]\]. In plants and trypanosomatids, snoRNA genes are present in polycistronic clusters which encode both C/D and H/ACA snoRNAs \[[@B9],[@B17]\]. A particular genomic organization, the intronic gene cluster, was first found in rice and then in *Drosophila melanogaster*\[[@B32],[@B33]\]. Moreover, a unique genomic organization (dicistronic tRNA-snoRNA genes) has been characterized exclusively in plants \[[@B34]\]. The genomic organization of snoRNA genes differs largely in fungi. In the budding yeast *Saccharomyces cerevisiae*, apart from seven intronic snoRNA genes, the majority of snoRNA are encoded by independent genes as well as five polycistronic snoRNA gene clusters \[[@B12]\]. In contrast, most box C/D snoRNA genes from the fission yeast *Schizosaccharomyces pombe*are intron-encoded. This raises the question about the genomic organization and expression modes of snoRNA genes in the fungus kingdom. It is well known that multicellular fungi dominate the population of fungi. However, little is known about snoRNAs in multicellular fungi. It was thus of interest to determine the snoRNA genes from a multicellular fungi to shed light on these characteristics.

*Neurospora crassa*is a filamentous fungus sharing key components with animal cells in cellular physiology and genetics, contributing to the fundamental understanding of the genome defense system, DNA methylation, post-transcriptional gene silencing, cellular differentiation and development \[[@B35]\]. As a model eukaryote, the genome of *N. crassa*has been completely sequenced \[[@B36]\]. However, only four box C/D snoRNAs, snR39, snR52, snR60, snR61 (Rfam) were annotated in *N. crassa*. Recently, we identified three U3 snoRNA genes from *N. crassa*; each of them is independently transcribed and contains a small intron \[[@B37]\](Table [1](#T1){ref-type="table"}). It is evident that the majority of the *N. crassa*snoRNAs remain to be identified. Meanwhile, a comparative genome analysis between yeast and multicellular fungi will provide insights into the evolution of snoRNA genes in the fungus kingdom. In this study, by combining computational and experimental methods, an extensive analysis of snoRNA genes from *N. crassa*was performed. Here, we present the first comprehensive list of two major families of snoRNAs from *N. crassa*, and further discuss the characteristics and evolutionary significance of the snoRNA genes.

###### 

Box C/D snoRNAs identified in *N. crassa*

                                                                Homologs                                    
  ----------- ----- ----- ------ ----------------- ------ ----- ---------- -------- --------- ------------- --------
  Nc CD1      125   III   C, N   26S-Am2242        10/0   D\'   \-         snR13    \-        \-            Intron
  Nc CD2      99    V     C      26S-Um2379        13/0   D\'   snR66      snR66    \-        \-            IR
  Nc CD3      90    I     C, N   26S-Um2840        14/0   D\'   \-         \-       snoR29                  
  Nc CD4      81    V     C, N   18S-Cm49          13/0   D\'   \-         \-       \-        \-            Intron
  Nc CD5      80    VI    C      26S-Am856         10/0   D     snR60-I    snR72    snoR72Y   \-            Intron
                                 26S-Um2383        12/0   D\'   snR78      snR78    snoR37    U52           
  Nc CD6      76    I     C      26S-Um2687        11/0   D\'   snR51-I    snR51    \-        U41           Exon
  Nc CD7      84    VI    C      26S-Gm2250        12/0   D\'   snR75      snR75    U15       U15           Intron
  Nc CD8      85    I     C      26S-Gm2751        13/0   D\'   snR48      snR48    \-        U60           IR
  Nc CD9      81    I     C      18S-Gm1122        14/0   D     snR41-II   snR41    \-        \-            Intron
  Nc CD10     104   I     C, N   26S-Um1039        12/0   D     \-         \-       \-        \-            Intron
                                 26S-Am3264        13/0   D\'   \-         \-       \-        \-            
  Nc CD11     79    I     C      18S-Am793         13/0   D\'   snR53      snR53    snoR53Y   \-            Intron
                                 U6-Am47           11/0   D\'   snR53      \-       \-        mgU6-47       
                                 26S-Am356         15/0   D     \-         \-       \-        \-            
  Nc CD12     85    VI    C      26S-Cm2159        10/0   D\'   \-         snR76    Ath119b   HBII-180      Intron
  Nc CD13     84    VI    C      18S-Am538         12/0   D     snR41-I    snR41    snR41Y    U62A/B        Intron
  Nc CD14     75    IV    C      26S-Am2288        10/0   D\'   \-         \-       U79       U79           Intron
  Nc CD15     73    I     C, N   18S-Am159         11/0   D\'   \-         \-       \-        \-            Intron
                                 tRNA^Thr^-Um114   12/1   D     \-         \-       \-        \-            
  Nc CD16     122   II    C      26S-Gm2357        13/0   D\'   snR81      snR190   \-        HBII-99       Intron
                                 26S-Gm1907               D\'   \-         \-       \-        U50           
  Nc CD17     73    I     C      18S-Am154         13/0   D     \-         \-       \-        U45A/C        Intron
                                 26S-Gm2875        12/0   D\'   \-         \-       snoR34    HBII-210      
  Nc CD18     88    V     C, N   18S-Cm1004        11/0   D     snR79      snR79    \-        \-            Intron
  Nc CD19     75    III   C      18S-Gm1423        13/0   D\'   snR56      snR56    snoR19    U25           Intron
  Nc CD20     75    VI    C, N   26S-Um2372        13/0   D     snR88      \-       snoR58    \-            Intron
  Nc CD21     69    VI    C      18S-Am28          13/0   D\'   snR74      snR74    U27       U27           Intron
  Nc CD22     79    I     C      26S-Um1866        14/0   D\'   snR62      snR62    U34       U34           Intron
                                 18S-Um893         11/0   D     \-         \-       \-        \-            
  Nc CD23     72    V     C, N   26S-Gm2773        11/0   D\'   snR38      snR38    snoR38Y   snR38         Intron
  Nc CD24     75    VI    C      18S-Um575         13/0   D\'   snR77      snR77    snoR77Y   HBII-135      Intron
                                 U5-Am62           15/0   D     \-         \-       \-        \-            
  Nc CD25     81    I     C, N   26S-Am846         13/0   D\'   \-         \-       \-        \-            Intron
  Nc CD26     77    I     C      U2-Gm183          11/0   D\'   \-         \-       \-        \-            Intron
  Nc CD27     85    VI    C      26S-Am2904        15/0   D\'   snR71      snR71    U29       U29           Intron
                                 26S-Cm2906        15/0   D\'   snR69      snR69    snoR69Y   \-            
  Nc CD28     78    II    C      26S-Am1845        12/0   D\'   \-         \-       snoR33    U95           Intron
                                 26S-Am1859        14/0   D     \-         \-       \-        \-            
  Nc CD29     101   II    C      U2-Am31           16/0   D     \-         \-       \-        SCARNA9       Intron
                                 5.8S-Am42         14/0   D\'   \-         \-       snoR9     \-            
  Nc CD30     84    I     C, N   18S-Cm584         12/0   D\'   \-         \-       \-        \-            IR
  Nc CD31     101   VI    C, N   26S-Cm2917        13/0   D\'   snR73      snR73    U35       U35           Intron
  Nc CD32     82    VII   C      18S-Am161         11/0   D     \-         \-       snoR18    U44           Intron
                                 18S-Um167         11/0   D\'   \-         \-       snoR122   U45A/B        
  Nc CD33     102   III   C      26S-Am2218        13/0   D     snR63      snR63    U46       U46           Intron
  Nc CD34     69    IV    C      18S-Um1265        12/0   D\'   snR55      snR55    snoR34    U33           Intron
  Nc CD36     90    I     C      26S-Cm2299        10/0   D\'   snR64      snR64    snoR44    U74           Intron
  Nc CD37     97    II    C      Cleavage                       U14        U14      U14       U14           Intron
                                 18S-Cm411         15/0   D     U14        U14      U14       U14           
  Nc CD38\*   80    IV    C      26S-Am1114        12/0   D\'   snR61      snR61    U38       U38           Intron
                                 26S-Am2858        10/0   D\'   \-         \-       \-        \-            
  Nc CD39     73    I     C      26S-Am897         13/0   D\'   snR83      \-       \-        \-            Intron
                                 26S-Am375         11/0   D     \-         \-       \-        \-            
  Nc CD40     107   IV    C, N   26S-Am2062        11/0   D\'   \-         \-       \-        \-            Intron
  Nc CD41     72    II    C      18S-Gm1423        12/0   D\'   snR56      snR56    snoR19    U25           Intron
                                 26S-Cm1489        12/0   D     \-         \-       U49       mgh28S-2409   
  Nc CD42\*   92    II    N, R   18S-Am417         12/0   D     snR52      snR52    \-        U83           Intron
  Nc CD43     96    VI    N, R   18S-Gm559         11/0   D\'   snR80      \-       \-        \-            Intron
  Nc CD44     85    IV    N, R   18S-Um1227        15/0   D\'   snR82      \-       snoR14    HBII-55       Intron
                                 26S-Cm776         11/0   D     \-         \-       \-        \-            
  Nc CD45     102   I     N, R   26S-Um3021        11/0   D     \-         \-       \-        \-            IR
  Nc CD46A    89    VII   N, R   26S-Am635         11/0   D\'   U18        U18      U18       U18           Intron
  Nc CD46B    89    I     N, R   26S-Am635         12/0   D\'   U18        U18      U18       U18           Intron
  Nc CD47\*   75    III   N, R   26S-Gm785         16/0   D     snR39b     snR39b   snR39BY   snR39b        Intron
  Nc CD48\*   91    V     N, R   26S-Am797         14/0   D\'   snR60-I    snR60    U80       U80/U77       Intron
                                 26S-Gm888         17/0   D     snR60-II   snR60    U80       U80           
  Nc CD49     91    I     N, R   26S-Um2682        12/0   D     \-         snR67    \-        \-            Intron
                                 18S-Am971         13/0   D\'   snR54      snR54    U59       U59A/B        
  Nc CD50     98    I     N, R   26S-Cm1418        15/0   D\'   U24        U24      U24       U24           IR
  Nc CD51     87    VII   N, R   26S-Am1430        13/0   D\'   U24b       U24      U24       U76           Intron
  Nc CD52     177   VII   C, N   tRNA-Am43         11/0   D\'   \-         \-       \-        \-            IR
                                 tRNA^Leu^-Am90    12/0   D\'   \-         \-       \-        \-            
  Nc CD53     212   IV    C, N   Orphan                         \-         \-       \-        \-            IR
  Nc CD54     125   V     C, N   26S-Um667         10/0   D     \-         \-       \-        \-            IR
  Nc CD55     137   IV    C, N   Orphan                         \-         \-       \-        \-            Intron
  Nc U3A      262   I     C, N   Cleavage                       \-         \-       \-        \-            RE
  Nc U3A-2    184   I     C, N                                  \-         \-       \-        \-            RE
  Nc U3A-3    75    I     C, N                                  \-         \-       \-        \-            RE
  Nc U3B      270   I     C, N   Cleavage                       \-         \-       \-        \-            RE
  Nc U3B-2    191   I     C, N                                  \-         \-       \-        \-            RE
  Nc U3C      275   II    \-     Cleavage                       \-         \-       \-        \-            RE

^a^The box C/D snoRNAs were numbered according to the order of identification. ^b^Len, cDNA length of the snoRNA. ^c^Chr, chromosomal location of snoRNA gene. ^d^Exp, expression situation. C, N, R, snoRNA was identified by cDNA library, northern blotting analysis, and reverse transcription analysis, respectively. ^e^target match, (Watson-crick pairs+G\*U)/mismatch. ^f^Gp, guide position. ^g^IR, Intergenic region; RE, Repeat element. The genes marked with asterisks indicate that the genes were annotated in the *Neurospora crassa*database but were not detected by experimental methods. The data for *S. p*snoRNAs were cited from Luo (2004) \[[@B38]\] and Bi *et al*. (2007) \[[@B39]\]. *A. t*snoRNAs and modifications are from the plant database <http://bioinf.scri.sari.ac.uk/cgi-bin/plant_snorna/conservation>. *S. c*snoRNAs and modifications are from the yeast snoRNA database at UMass-Amberst <http://people.biochem.umass.edu/fournierlab/snornadb/main.php>. Abbreviation: *S. p*, *S. pombe*; *S. c*, *S. cerevisia*; *A. t*, *A. thaliana*; *H. s*, *H. sapiens*.

Results
=======

Identification of 55 box C/D and 20 box H/ACA snoRNAs from *N. crassa*
----------------------------------------------------------------------

We initially carried out the genome-wide analysis of snoRNAs from *N. crassa*by employing the snoscan \[[@B12]\] and snoGPS programs \[[@B13]\]. From this database search, 89 box C/D and 131 box H/ACA snoRNA candidates were predicted (see Methods). To validate the snoRNA candidates and identify more novel snoRNAs from *N. crassa*, the box C/D and box H/ACA snoRNA-specific library of *N. crassa*were respectively constructed from mixed-stage mycelium and spores using anchored primers (18, and see Methods). To exclude the highly abundant clones and enrich the novel RNA species in our analysis, the radiolabelled oligonucleotides were used to screen the cDNA libraries (\~1800 clones in the box C/D and \~ 4000 clones in box H/ACA snoRNA libraries). Subsequently, a total of 338 and 278 clones from box C/D and box H/ACA snoRNA libraries were sequenced, respectively. Taken together, 65 snoRNAs including 45 box C/D (Table [1](#T1){ref-type="table"}) and 20 box H/ACA snoRNAs (Table [2](#T2){ref-type="table"}) were identified. Twenty eight box C/D snoRNAs from the cDNA library were covered by the snoscan results. However, only three H/ACA snoRNAs overlapped with snoGPS results. Because the data from the computational search of H/ACA snoRNAs may include excessive false-positive candidates, they were not included for further analyses in this study.

###### 

Box H/ACA snoRNA genes in *N. crassa*

                                                  Homologs                             
  ---------- ----- ----- ------ ----------- ----- ---------- -------- -------- ------- -------------
  Nc ACA1    136   III   N, R   18S-Ψ105    H     \-         snR44    \-       ACA36   Intron
                                26S-Ψ1037   ACA   \-         snR44    \-       \-      
  Nc ACA2    159   III   N, R   26S-Ψ1868   H     \-         \-       \-       \-      IR
                                26S-Ψ2313   ACA   \-         snR82    \-       \-      
  Nc ACA3    217   V     C, N   26S-Ψ401    H     \-         \-       \-       \-      IR
                                26S-Ψ2095   ACA   \-         snR3     \-       ACA6    
  Nc ACA4    206   II    C, N   18S-Ψ463    H     \-         snR189   \-       \-      IR
  Nc ACA5    187   I     C, N   18S-Ψ996    ACA   \-         snR31    snoR5    ACA8    IR
  Nc ACA6    165   VII   C, N   26S-Ψ940    H     \-         snR8     \-       ACA56   IR
                                26S-Ψ1105   ACA   snR5       snR5     \-       \-      
  Nc ACA7    167   V     C, N   Orphan      ACA   \-         \-       \-       \-      IR
  Nc ACA8    192   II    C, N   18S-Ψ1509   ACA   \-         \-       \-       \-      IR
  Nc ACA9    201   V     C, N   Orphan            \-         \-       \-       \-      Intron
  Nc ACA10   309   II    C, N   Orphan            \-         \-       \-       \-      3\'UTR
  Nc ACA11   176   I     C, N   Orphan            \-         \-       \-       \-      IR
  Nc ACA12   296   II    C, N   Orphan            \-         \-       \-       \-      IR
  Nc ACA13   208   I     C, N   Orphan            \-         \-       \-       \-      IR
  Nc ACA14   234   II    C, N   26S-Ψ984    ACA   snR5       snR5     snoR81   ACA52   IR
  Nc ACA15   233   II    C, N   26S-Ψ2902   H     \-         snR37    \-       ACA10   IR
  Nc ACA16   189   II    C, N   Orphan            \-         \-       \-       \-      Exon+3\'UTR
  Nc ACA17   189   II    C, N   18S-Ψ1733   H     \-         \-       snoR88   \-      IR
  Nc ACA18   186   V     C, N   26S-Ψ2309   H     \-         \-       \-       E2      IR
  Nc ACA19   178   V     C, N   26S-Ψ1666   ACA   \-         \-       \-       \-      IR
  Nc ACA20   160   V     N, R   26S-Ψ2228   ACA   \-         snR84    \-       Undet   IR

^a^All the box H/ACA snoRNAs were numbered according to the order of identification. ^b^Len, cDNA length of the snoRNA. ^c^Chr, chromosomal location of snoRNA gene. ^d^Exp, expression situation. C, N, R, snoRNA was identified by cDNA library, northern blotting analysis, and reverse transcription analysis, respectively. ^e^Gp, guide position. ^g^IR, Intergenic region. The data for *S. p*snoRNAs were cited from Luo (2004) \[[@B38]\]. \"Undet\" indicates that the snoRNA has not been identified in the human genome although the corresponding modification site was detected. Abbreviation: *S. p*, *S. pombe*; *S. c*, *S. cerevisia*; *A. t*, *A. thaliana*; *H. s*, *H. sapiens*.

The snoRNA candidates identified by cDNA cloning or the snoscan program were subsequently confirmed by northern blot and/or reverse transcription analyses. The expression of 27 box C/D and all 20 box H/ACA snoRNAs were positively detected as expected (Figure [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Among these snoRNAs, the sequence of CD31 snoRNA obtained from the cDNA cloning appears uncompleted; it corresponds to the second half of CD31 full-length which is further validated by the northern blotting.

![**Northern blot and RT analyses of box C/D snoRNAs from N. crassa**. A. Northern blot analyses of box C/D snoRNAs. B. Reverse transcription analyses of box C/D snoRNAs generated from the computational screen. Lane M, molecular weight marker (pBR322 digested with Hae III and 5\'-end -labeled with \[γ-^32^P\]ATP).](1471-2164-10-515-1){#F1}

![**Northern blot and RT analyses of box H/ACA snoRNAs from N. crassa**. A. Northern blot analyses of box H/ACA snoRNAs. B. Reverse transcription analyses of the three box H/ACA snoRNAs overlaps with the computational screen. Lane M, molecular weight marker (pBR322 digested with Hae III and 5\'-end -labeled with \[γ-^32^P\]ATP.](1471-2164-10-515-2){#F2}

Together, through the combination of computational analysis and construction of the specialized cDNA libraries, 55 box C/D and 20 box H/ACA snoRNAs were identified and all the snoRNAs are denominated according to the order of identification (Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

In most cases (86%) the C and D boxes in snoRNAs are highly conserved when compared to the consensus sequence (UGAUGA and CUGA, see Additional file [1](#S1){ref-type="supplementary-material"}). However, the C\' and D\' box are nonconserved and exhibit much more sequence-degeneracy than their C and D box counterparts. In some instances, the C\' and D\' box cannot be unambiguously inferred as a result of the absence of the functional region. Generally, the box C/D snoRNAs from *N. crassa*are similar to their metazoan and yeast counterparts in size. However, the sizes of box H/ACA snoRNAs from *N. crassa*are peculiar. Almost all of them are larger than 160 nt (Figure [2](#F2){ref-type="fig"}), reminiscent of some irregular box H/ACA snoRNAs in *S. cerevisiae*. These observations show that the *N. crassa*snoRNAs have their own unique sequence and structural features (see Additional file [2](#S2){ref-type="supplementary-material"} and [3](#S3){ref-type="supplementary-material"}).

Functional properties of the *N. crassa*box C/D and box H/ACA snoRNAs
---------------------------------------------------------------------

Based on the modification rules of snoRNAs \[[@B2]\] , 55 box C/D snoRNAs from *N. crassa*were predicted to direct 71 methylations. These include 64 methylations on rRNAs which comprise 43 methyls on 26S rRNA, 20 methyls on 18S rRNA and one methyl on 5.8S rRNA (see Additional file [4A](#S4){ref-type="supplementary-material"}). The remnant seven methylations consist of four methyls on snRNAs and three methyls on tRNAs (see Additional file [4B](#S4){ref-type="supplementary-material"} and [4C](#S4){ref-type="supplementary-material"}). Furthermore, the structure and function elements of U14 which participate in the processing of pre-rRNA were unambiguously identified. Interestingly, two different methylated sites were predicted to be guided by the same functional element of a single snoRNA CD27. Two box C/D snoRNAs (CD53 and CD55) lack the sequences complementary to either rRNAs or snRNAs and therefore belong to orphan snoRNAs. Fourteen box H/ACA snoRNAs were predicted to guide 17 pseudouridine sites of rRNAs (see Additional file [5](#S5){ref-type="supplementary-material"}), and no pseudouridine sites on snRNAs were predicted. The remaining six box H/ACA snoRNAs were also classified into an orphan snoRNA family lacking functional region complementary to rRNA, tRNA or snRNA. A different modification pattern appears in *N. crassa*as compared to the two yeasts *S. cerevisiae*, and *S. pombe*(see discussion)\[[@B38],[@B39]\].

Interestingly, a novel snoRNA, CD29, possesses two guide elements that can form duplexes with U2 snRNA and 5.8S rRNA for 2\'-O-methylation. Primer extension mapping of 2\'-O-methylated nucleotides of the U2 snRNA and 5.8S rRNA in the presence of low concentration of dNTPs resulted in stop signals at the G32 and A43 residues, indicating that U2-A31 and 5.8S-A42 are methylated (Figure [3](#F3){ref-type="fig"}). We have identified cognates of CD29 in other filamentous fungi, however, these cognates only possess the guide sequence for the methylation of U2 snRNA. This suggests that CD29 evolves from the snoRNA with a single guide function. This is reminiscent of the human small Cajal body-specific RNAs (scaRNAs) that can guide modification of the RNA polymerase II-transcribed snRNAs such as U2 snRNA. The comparative analyses revealed that CD29 and its homologs in fungi have one functional element similar to that of human SCARNA9 which was first known as Z32 (GeneBank accession no. [AJ009638](AJ009638)), and therefore was homologous to this human scaRNA. In addition, we characterized a multi-function box C/D snoRNA, CD11, in *N. crassa*. CD11 has the potential to direct a methylation in U6 snRNA, and two methylations in 18S and 26S rRNAs, respectively (Figure [3](#F3){ref-type="fig"}). Interestingly, the CD11 is also partially similar to mgU6-47 in mammals \[[@B40]\], but possesses a novel function that can guide a *N. crassa*-specific methylation on 26S rRNA at A356.

![**Base-pairing model and verification of modification guided by CD11 (A) and CD29 (B)**. Black dots indicate nucleotides predicted to be methylated. Lane H, control reaction at 1.0 mM dNTP; Lane L, primer extension at 0.004 mM dNTP, and A, C, G and T lanes, the rDNA sequence ladder. Black triangles indicate potential methylation sites.](1471-2164-10-515-3){#F3}

Genomic organization and expression of the snoRNAs in *N. crassa*
-----------------------------------------------------------------

The genomic organization of the snoRNA genes in *N. crassa*exhibits great diversity. Among the 55 box C/D snoRNAs, forty five snoRNA genes are intron-encoded in protein-coding or non-coding host genes. The remaining nine were found in the intergenic regions with a putative polymerase II promoter upstream and appeared independently transcribed. Meanwhile, six gene clusters that only encode box C/D snoRNAs were identified from *N. crassa*. Interestingly, an exon-encoded snoRNA (CD6) was identified in the snoRNA gene cluster III in contrast to another two intron-encoded snoRNAs (CD9 and CD17) in the same cluster (Figure [5](#F5){ref-type="fig"}). Of 20 box H/ACA snoRNA genes, 16 are located in intergenic regions and two are intron-encoded. In particular, two snoRNA genes (ACA10 and ACA16) are located in the 3\' UTR of two hypothetical protein genes, one of which is similar to phosphoglycerate mutase. Obviously, different strategies dominate in the expression of the two families of snoRNA genes in *N. crassa*.

![**Schematic representation of snoRNA gene clusters in N. crassa**. The open and gray boxes represent snoRNAs and exons, respectively. The number below indicates the length (in nucleotides) of introns. Thinner lines indicate introns. Note: figure not drawn to scale.](1471-2164-10-515-5){#F5}

In accordance with the mode of one snoRNA per intron in vertebrates \[[@B4]\], a large proportion of the box C/D snoRNA genes (45 of 55) are located within introns of the host genes. The distances from the intronic snoRNA genes to the 3\' splice sites of introns, which has been proven to be important for the effective processing of intronic snoRNAs from their host mRNA precursors \[[@B41],[@B42]\], resemble those in *D. melanogaster*\[[@B32],[@B41],[@B42]\]. The distances from the snoRNA genes to the 5\' splice sites appear to mainly be between 41 to 60 nt, similar to those in human\[[@B41]\] (Figure [4](#F4){ref-type="fig"}).

![**The distance distributions from the intronic snoRNA genes to the 3\' and 5\' splicing sites of host gene introns**. The gray and black bars represent space lengths from the 3\' and 5\' splicing sites (SS), respectively, to the snoRNA genes.](1471-2164-10-515-4){#F4}

Remarkably, five (cluster I to V) of the six box C/D snoRNA gene clusters arehighly conserved between yeast and *N. crassa*(Figure [5](#F5){ref-type="fig"}). Although these host genes were not well annotated for their introns and exons in the *N. crassa*genome, canonical intron splicing sequences were observed flanking every cluster of snoRNA genes. To further confirm this observation, the mature RNA transcripts were identified with the expected sizes by cloning and sequencing of RT-PCR products. It is worth noting that two snoRNA genes, CD16 and CD37, in the cluster V are validated to be co-transcribed by RT-PCR and sequencing, though each of the snoRNA genes in the cluster has a putative promoter upstream. Intriguingly, the putative promoter upstream of CD37, a homologue of U14, would play a role in guaranteeing and promoting the function of U14 that has been demonstrated vital in diverse eukaryotes. Our results further revealed that the genomic organization of the host genes for these five clusters is most like the UHG gene in animals. The host genes of Cluster I to V only contain short open reading frames with length ranging from 159 bp to 267 bp, suggesting the little potential for protein coding just like the *gas 5*\[[@B43]\].

Unexpectedly, various alternative splicing events were found in the processing of polycistronic transcripts from the snoRNA gene clusters I and II by analyzing cDNA sequences from RT-PCR of the transcripts (Figure [6](#F6){ref-type="fig"}). In cluster I, two alternatively spliced transcripts, differing by the absence of exon 2 or exon 2 plus exon 3 were detected. The pattern of alternative splicing in the expression of cluster II was contingent on an alternative 3\' splice site that allows the lengthening or shortening of exon 3.

![**Alternative splicing in the expression of snoRNA gene cluster I and II in N. crassa**. The open and black boxes represent snoRNAs and exons, respectively. The number below indicates the length (in nucleotides) of exons and introns. Thinner lines indicate introns and dashed lines indicate splicing activities. Arrows indicate the primers used in RT-PCR analysis.](1471-2164-10-515-6){#F6}

Discussion
==========

High diversity of post-transcriptional modification predicted by snoRNAs in fungi
---------------------------------------------------------------------------------

Identification of guide snoRNAs in diverse organisms can provide valuable information towards understanding RNA modification patterns and their function \[[@B18]\]. It is interesting to compare the pattern of modifications on target RNAs of *N. crassa*to those described in the two yeasts, *S. cerevisiae*and *S. pombe*. Among 71 methylations predicted by the guide snoRNAs in *N. crassa*, 32 represent the most highly conserved modifications shared by the multicellular fungi and the yeasts, and 31 (43.7%) are modifications that have not yet been reported in other fungi when compared with the two unicellular yeasts(Figure [7](#F7){ref-type="fig"}). In the yeasts, only ten and eight methylations are *S. cerevisiae*-specific and *S. pombe*-specific, respectively. Our results imply a more complex modification pattern in multicellular fungi than in unicellular yeasts. They also reveal the high diversity of post-transcriptional modification of RNAs in the fungus kingdom as it has been shown that about 40% of methylations are species-specific in a protozoan *Trypanosoma*\[[@B17]\]. The species-specific modifications highlight the different modification patterns and their peculiar importance. Although eliminating a single modification does not have a dramatic effect on the ribosome \[[@B44]\], loss of three to five modifications in an intersubunit bridge of the ribosome (helix 69) impairs growth and causes broad defects in ribosome biogenesis and activity \[[@B45]\]. On the other hand, early studies have demonstrated that ribosome modifications play roles in determining antibiotic resistance or sensitivity \[[@B15],[@B46]\]. Thus the species-specific modifications have potential use in finding therapeutic targets for prevention and treatment of diseases caused by some eukaryotic pathogens.

![**Venn diagram of the relationship of methylations in three fungi**. The number of each part of the methylations is shown. Abbreviation: *N.c*, *N. crassa*; *S. c*, *S. cerevisiae*; *S. p*, *S. pombe*.](1471-2164-10-515-7){#F7}

Another interesting observation in this study was the presence of duplexes between box C/D snoRNAs and tRNAs (tRNA^Trp^and tRNA^Leu^from *N. crassa*Database). Duplexes between tRNA and snoRNAs have been also found in *C. elegans*\[[@B24]\] and recently in *Plasmodium falciparum*\[[@B47]\]. tRNA modification guided by snoRNAs has been also reported in Archaea \[[@B23]\]. This study provides for the first time a prediction of fungal snoRNAs and their potential target sites in tRNAs, although these remain to be confirmed by further experiments.

Structural and functional evolution of snoRNAs in fungi
-------------------------------------------------------

Our study demonstrates the extensive separation and recombination of functional regions occurring during the evolution of snoRNA genes in fungi. For instance, the CD5 snoRNA in *N. crassa*possesses two conserved guiding elements. In *S. cerevisiae*, however, the conserved function of CD5 is executed by two independent snoRNAs, snR72 and snR78, with a single functional element \[[@B48]\] (Figure [8](#F8){ref-type="fig"}). This suggests that CD5 may have evolved as a double-guide snoRNA through recombination of two different halves of two ancestral single-guide snoRNAs. The other possibility is that a gene duplication of a double-guide snoRNA gene in *S. cerevisiae*led to specialization of each paralog to only target one modification site followed by loss of the other guide element for both paralogs. Another example is CD50 and CD51 that carry a conserved guiding function for U24 and U24b in *S. pombe*, respectively. In contrast, the U24 in *S. cerevisiae*has two guiding functions. Comparative analyses revealed that the structure and function of U24 are well conserved among the budding yeast and the flowering plants *A. thaliana*and rice, but the homologues of the *S. cerevisiae*U24 exist as two independent snoRNAs in other distant eukaryotes, such as human and mouse \[[@B49]\]. This suggests that U24 snoRNA gene has evolved in two pathways, with one leading to a dual functional snoRNA gene and the other separating the guiding functions and giving rise to two independent snoRNA genes.

![**Alignment of homologous snoRNAs from three multicellular fungi and two yeasts**. Conserved box elements are bold and boxed regions denote antisense elements. Stars indicate conserved nucleotides. Sp, *S. pombe*; Sc, *S. cerevisiae*; An, *Aspergillus niger*; Mg, *Magnaporthe grisea*; Nc, *N. crassa*.](1471-2164-10-515-8){#F8}

It has been demonstrated the reciprocal evolutionary change between snoRNA complementary region and their rRNA target sequence in plants and nematodes\[[@B9],[@B24]\]. Our analyses indicate that co-evolution between snoRNAs and rRNAs exists widely in *N. crassa*(Figure [9](#F9){ref-type="fig"}) and plays an important role in preservation of phylogenetic conserved methylated sites of rRNAs which is essential for protein synthesis.

![**Coevolution between snoRNAs and their targets**. A. Nucleotides of box C/D snoRNAs in the complementary region were changed in coordination with its target rRNA maintaining phylogenetical conservation of rRNA methylated sites. B. Nucleotides changed in box H/ACA snoRNAs respond to specific changes in the 18S rRNA of *N. crassa*. The nucleotides marked by black dot represent the 2\'-O-methylation. Basepairs changed are indicated by arrows.](1471-2164-10-515-9){#F9}

RIP may impact on the generation of snoRNA isoforms by gene duplication and transposition
-----------------------------------------------------------------------------------------

SnoRNA gene isoforms or variants exist widely in diverse organisms, particularly in plants. For example, 97 box C/D snoRNAs with a total of 175 different gene variants were identified in the *A. thaliana*genome \[[@B50]\], and 346 gene variants encoding 120 box C/D snoRNAs were found in *Oryza Sativa*\[[@B9]\]. Compared with the plant snoRNAs, only a paucity of yeast snoRNA paralogs was detected because of a relatively small compact genome (\~12 Mb for *S. cerevisiae*). The *N. crassa*genome (\~ 40 Mb) is three-fold larger than that of the yeast; however, most snoRNA genes in this species are singleton. Why are the snoRNA genes devoid of isoforms in the *N. crassa*genome? It is known that a mutagenic process termed repeat-induced point mutation (RIP) has a profound impact on *N. crassa*genome evolution, which has greatly slowed the creation of new genes through genomic duplication and resulted in a genome with an unusually low proportion of closely related genes \[[@B51]\]. Of the predicted 10082 protein-coding genes, only six pairs (12 genes) share \>80% nucleotide or amino-acid identities in their coding sequences \[[@B36]\]. RIP identifies duplications that are greater than \~400 bp (\~1 kb in the case of unlinked duplications) and induces C:G to T:A during the sexual cycle \[[@B52],[@B53]\]. Early studies have provided clear evidence of retrotransposons inactivated by RIP \[[@B54],[@B55]\]. The analysis of the *N. crassa*genome sequence also revealed a complete absence of intact mobile elements \[[@B36]\]. Therefore the creation of new genes including snoRNA genes or their host genes through gene duplication and transposition seems to be impeded. It has been proposed that most, if not all paralogs in *N. crassa*duplicated and diverged before the emergence of RIP \[[@B51]\]. We have identified three U3 snoRNA gene variants, NcU3A, NcU3A-2 and NcU3A-3 in *N. crassa*(37). The sequence analysis revealed that these molecules have undergone nucleotide substitutions rather than RIP according to the calculation method previously reported \[[@B36]\]. In the case of CD46A and CD46B, we speculate that the two snoRNA gene isoforms may have duplicated and diverged before the emergence of RIP.

Alternative splicing in the expression of non-coding RNA genes with introns
---------------------------------------------------------------------------

It is well known that alternative splicing is an important and widespread process where one gene produces more than one type of mRNA which is then translated into different proteins in multicellular organisms \[[@B56]\]. Bioinformatic analysis indicates that 35-65% of human genes are involved in alternative splicing, which contributes significantly to human proteome complexity \[[@B57],[@B58]\]. However, alternative splicing is rarely reported for non-coding RNA genes which encode multiple introns. In this study, we identified several alternative splicing events that occurred in the processing of RNA precursors transcribed from the snoRNA gene cluster I and II of *N. crassa*. It has been reported that the mouse *gas5*gene, a non-coding RNA and snoRNA host gene, had four alternative splicing transcripts \[[@B43]\]. Although different in snoRNA composition, the snoRNA gene clusters in *N. crassa*are most like UHG genes resembling *gas5*. Our results show that alternative splicing occurs frequently in the expression of snoRNA host genes in lower eukaryotes. This lends support to the concept that alternative splicing may be an ancient mechanism in regulating the expression of both protein-coding and non-coding RNA genes with introns. More work is necessary to elucidate the biological significance of the alternative splicing in the expression of non-coding RNA genes.

Conclusion
==========

In this study, we report the first extensive identification of box C/D and box H/ACA snoRNAs from the filamentous fungus *N. crassa*using a combination of computational and experimental method. The repertoire characteristics, targets, genomic organization and the unique function of the *N. crassa*snoRNA genes were extensively compared with those of potential orthologues in close and distant organisms such as *S. pombe*, *S. cerevisiae, A. niger*, *M. grisea*, *A. thaliana*and *H. sapiens*. Our results improve annotation of snoRNA genes in the *N. crassa*genome, an important model filamentous fungus, and provide insights into the characteristics and evolutionary significance of the snoRNA genes in the fungus kingdom.

Methods
=======

Strains and Media
-----------------

The *N. crassa*wild-type strain (As 3.1604, purchased from the China General Microbiological Culture Collection Center) was used for the construction of the cDNA library and all RNA analyses. The strain was grown in PSA medium (2% sucrose, 20% extract of potato) at 30°C. The *Escherichia coli*strain TG1 grown in 2YT (1.6% Bacto tryptone, 1% yeast extract, 0.5% NaCl) liquid or solid medium was used for cloning procedures.

Construction and screening of cDNA library
------------------------------------------

We prepared total RNA from *N. crassa*culture according to the guanidine thiocyanate-phenol-chloroform procedure described by Chomoczynski *et al*\[[@B59]\]. Small RNA (\~20 μg) was fractionated by 50% PEG-8000 and 0.5 M NaCl. The construction of cDNA library were performed as described previously with minor modifications (see Additional file [6](#S6){ref-type="supplementary-material"}) \[[@B60]\]. After randomly sequencing clones, we employed dot hybridization to screen the colony PCR products with P47 and P48 as described by Liu *et al*. \[[@B37]\] We sequenced clones exhibiting the lowest hybridization signal.

Computational identification of box C/D snoRNA genes
----------------------------------------------------

Genomic sequences of *N. crassa*\[[@B36]\] available at <http://www.broad.mit.edu/annotation/genome/neurospora/Home.html> (*N. crassa*assembly 7) were downloaded and searched for potential box C/D snoRNAs target rRNA/snRNA using snoscan \[[@B12]\] with default parameters. Methylated sites prepared for the snoscan included the conserved methylated nucleotides of *S. cerevisiae*(yeast snoRNA database), *H. sapiens*(snoRNA-LBME-db), and *D. melanogaster*\[[@B32]\]. The snoscan results were processed by an in-house developed perl program for candidate selection. A sequence with the following characteristics was considered as candidate: ① box C motif bit score ≥ 7.48, box D motif bit score ≥ 8.05, ② the guide bit score ≥ 18.65, the guide sequence and the target sequence can form a concatenated 10 bp duplex with at most 1 GU pair allowed, or can form a concatenated 9 bp duplex with high GC content. ③ if the guide region is adjacent to the D\' box, the length of spaces between box C and guide sequence must be ≤ 20 bp. If the guide region is adjacent to the D box, the length of spaces between box C and guide sequence must be between 40 and 85 bp. ④ total sequence length between 75 bp and 130 bp, total overall bit score ≥ 20. The candidates within CDS region predicted by Broad/Whitehead Institute automatic gene calling software (a combination of manual annotation, FGENESH, GENEID, and GENEWISE) \[[@B36]\] were removed. The BLAST program \[[@B61]\] was used to search gene variants of all novel snoRNA genes to establish the snoRNA gene isoforms. About 1 kb of flanking sequences of the snoRNA gene candidates was searched further for possible box C/D snoRNA genes and additional non-canonical C/D gene candidates.

Northern blot analysis
----------------------

An aliquot of 30 μg total RNA was separated by electrophoresis on an 8% polyacrylamide gel containing 8 M urea and electrotransferred onto nylon membrane (Hybond-N+; Amersham) using semi-dry blotting apparatus (BioRad). After immobilizing RNA using a UV cross-linker, northern blot hybridization was performed as previously described \[[@B49]\].

Reverse transcription and mapping of ribose methylation
-------------------------------------------------------

Reverse transcription was carried out in a 20 μl reaction mixture containing 15 μg of total RNA and a corresponding 5\'-end-labeled primer. After denaturation at 65°C for 5 min and then cooling to 42°C, 200 units of M-MLV reverse transcriptase (Promega) were added and extension carried out at 42°C for 1 hour. The cDNA was separated on an 8% polyacrylamide gel (8 M urea) and then analyzed with an imager.

The mapping of rRNA methylated sites was determined by primer extension at low dNTP concentrations as described previously \[[@B40],[@B62]\]. Briefly, the *N. crassa*18S and 26S rDNA were amplified by PCR with the primer pair Nc18SF/Nc18SR and Nc26SF/Nc26SR, respectively, and then cloned into the pMD-18T vector (Takara). The plasmid DNA insert was directly sequenced with the same primer used for reverse transcription and run in parallel with the reverse transcription reaction on an 8% polyacrylamide gel (8 M urea).

RT-PCR analysis
---------------

15 μg of total RNA was reverse transcribed with 200 U of M-MLV reverse transcriptase (Promega) using the box C/D snoRNA gene cluster specific reverse primers (see Additional file [7](#S7){ref-type="supplementary-material"}) in a 20 μl reaction mixture as described above for reverse transcription and mapping of ribose methylations. The negative RT control was carried out without M-MLV reverse transcriptase. We designed two specific antisense oligonucleotides: the first reverse primer used in the reverse transcription reaction overlaps the last several nucleotides of the second reverse primer used in the PCR reaction to help avoid non-specific PCR products. After 1 h at 42°C, 2 μl of RT reaction was used for PCR amplification with the second reverse primer and the corresponding forward primer (see Additional file [7](#S7){ref-type="supplementary-material"}) in a final volume of 20 μl. The positive PCR control was performed on *N. crassa*genomic DNA with the same pair of primers. Negative PCR control was performed on 2 μl of the negative control RT reaction with the same pair of primers. The PCR program: 30 cycles of denaturation (30 s, 94°C), annealing (30 s, 50-55°C), and extension (1-2 min, 72°C), following by a final extension (10 min, 72°C). The PCR product was purified from a 1.5% agarose gel with the QIAquick Gel extraction Kit (QIAGEN) and cloned into pMD-18T vector (Takara) and transformed into the strain TG1 of *E. coli*. Positive clones were subsequently chosen for sequencing.

Oligonucleotides
----------------

Oligonucleotides used for construction of the cDNA library, northern blot analyses of novel snoRNAs and the primers for reverse transcription and RT-PCR experiments are not shown (see Additional file [7](#S7){ref-type="supplementary-material"}).

Database accession numbers
--------------------------

The sequences of all snoRNAs determined in this work have been deposited in the GenBank Nucleotide Sequence Databases under accession numbers [EU780925](EU780925) - [EU780999](EU780999) and [EU526091](EU526091)-[EU526095](EU526095).
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